Publicaciones en colaboración con investigadores/as de Hospital Universitario Puerta de Hierro (24)

2024

  1. Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivo

    Science translational medicine, Vol. 16, Núm. 734, pp. eadg7962

2023

  1. Clinical Profiles and Patterns of Kidney Disease Progression in C3 Glomerulopathy

    Kidney360, Vol. 4, Núm. 5, pp. 659-672

  2. Thrombotic microangiopathy in patients with malignant hypertension

    Nephrology Dialysis Transplantation, Vol. 38, Núm. 5, pp. 1217-1226

2022

  1. C3 glomerulopathy associated with monoclonal gammopathy: impact of chronic histologic lesions and beneficial effects of clone-targeted therapies

    Nephrology Dialysis Transplantation, Vol. 37, Núm. 11, pp. 2128-2137

  2. Development and validation of a nomogram to predict kidney survival at baseline in patients with C3 glomerulopathy

    Clinical Kidney Journal, Vol. 15, Núm. 9, pp. 1737-1746

  3. Longitudinal change in proteinuria and kidney outcomes in C3 glomerulopathy

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 37, Núm. 7, pp. 1270-1280

  4. Overcoming CAR-Mediated CD19 Downmodulation and Leukemia Relapse with T Lymphocytes Secreting Anti-CD19 T-cell Engagers

    Cancer immunology research, Vol. 10, Núm. 4, pp. 498-511

  5. Trispecific T-cell engagers for dual tumor-targeting of colorectal cancer

    Oncoimmunology, Vol. 11, Núm. 1, pp. 2034355

2021

  1. Validation of a Histologic Scoring Index for C3 Glomerulopathy

    American Journal of Kidney Diseases, Vol. 77, Núm. 5, pp. 684-695.e1

2020

  1. Familial risk of developing atypical hemolytic-uremic syndrome

    Blood

  2. Mycophenolate mofetil in c3 glomerulopathy and pathogenic drivers of the disease

    Clinical Journal of the American Society of Nephrology, Vol. 15, Núm. 9, pp. 1287-1298

2018

  1. ATTACK, a novel bispecific T cell-recruiting antibody with trivalent EGFR binding and monovalent CD3 binding for cancer immunotherapy

    OncoImmunology, Vol. 7, Núm. 1

2016

  1. Natural killer cell hyporesponsiveness and impaired development in a CD247-deficient patient

    Journal of Allergy and Clinical Immunology, Vol. 137, Núm. 3, pp. 942-945.e4

  2. Subcutaneous immunoglobulins: A promising alternative for immunomodulation?

    Current Pharmaceutical Design, Vol. 22, Núm. 41, pp. 6300-6305

2012

  1. Intravenous Immunoglobulin Treatment Increased Live Birth Rate in a Spanish Cohort of Women with Recurrent Reproductive Failure and Expanded CD56 + Cells

    American Journal of Reproductive Immunology, Vol. 68, Núm. 1, pp. 75-84

2011

  1. La Gestación como Fenómeno Inmunológico

    Revista Iberoamericana de Fertilidad y Reproduccion Humana, Vol. 28, Núm. 3, pp. 4

2009

  1. The MHC-related protein 1 (MR1) is expressed by a subpopulation of CD38+, igA+ cells in the human intestinal mucosa

    Histology and Histopathology, Vol. 24, Núm. 11, pp. 1439-1449

2008

  1. Survival of allogeneic hepatocytes transplanted into the thymus

    Cells Tissues Organs, Vol. 188, Núm. 3, pp. 270-279

2007

  1. Functional response of hepatocytes transplanted into Gunn rats stimulated with thyroid hormone

    Digestive Diseases and Sciences, Vol. 52, Núm. 1, pp. 210-216

2005

  1. Hepatic proliferation in Gunn rats transplanted with hepatocytes: Effect of retrorsine and tri-iodothyronine

    Cell Proliferation, Vol. 38, Núm. 3, pp. 137-146